Ionis Pharmaceuticals (IONS) Deferred Taxes (2013 - 2020)

Ionis Pharmaceuticals' Deferred Taxes history runs 7 years deep, the most recent figure standing at $340.1 million for Q4 2020.

• On a quarterly basis, Deferred Taxes rose 10754.14% year-over-year to $340.1 million in Q4 2020; TTM through Sep 2021 was $340.1 million, a 22140.18% increase from a year earlier, with the FY2020 full-year figure at $341.7 million, up 37411.42% from the prior year.
• Deferred Taxes rose to $340.1 million in Q4 2020 per IONS's latest filing, from $1.5 million in the prior quarter.
• Across five years, Deferred Taxes topped out at $340.1 million in Q4 2020 and bottomed at -$290.5 million in Q4 2018.
• The 4-year median for Deferred Taxes is $53000.0 (2016), against an average of $4.7 million.
• Biggest YoY gain for Deferred Taxes was 10754.14% in 2020; the steepest drop was 116.89% in 2020.
• Year by year, Deferred Taxes stood at $53000.0 in 2016, then tumbled by 548243.4% to -$290.5 million in 2018, then surged by 98.9% to -$3.2 million in 2019, then surged by 10754.14% to $340.1 million in 2020.
• Per Business Quant, the three latest IONS Deferred Taxes figures stand at $340.1 million (Q4 2020), $1.5 million (Q3 2020), and $2.5 million (Q2 2020).